Payment overview · 2025
General Payments
$15.80
1 reported records · 1 companies
Healthcare provider profile · identity verified
Alex Jonathan Dickert, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CRYSTAL RIVER, FL · NPI 1427342245
Verified facts
What the public records show
CMS Open Payments records show Alex Jonathan Dickert, M.D. received $15.80 in general payments during 2025 across 1 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Arexvy, Shingrix.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 95 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 62 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.80 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.80 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $15.80 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $15.80 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AREXVY arexvy |
2025 | Arexvy | 2024 | 34 | exact normalized | Medicare Part D |
| SHINGRIX shingrix |
2025 | Shingrix | 2024 | 95 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
34 | 34 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
95 | 75 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
62 | 26 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1292 | 438 |
| Amlodipine Besylate | Amlodipine Besylate | 892 | 298 |
| Levothyroxine Sodium | Levothyroxine Sodium | 833 | 288 |
| Lisinopril | Lisinopril | 673 | 227 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 509 | 181 |
| Losartan Potassium | Losartan Potassium | 487 | 171 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 448 | 95 |
| Omeprazole | Omeprazole | 423 | 132 |
| Alprazolam | Alprazolam | 390 | 94 |
| Gabapentin | Gabapentin | 372 | 122 |
| Tramadol Hcl | Tramadol Hcl | 347 | 90 |
| Metformin Hcl | Metformin Hcl | 340 | 129 |
| Metoprolol Succinate | Metoprolol Succinate | 334 | 118 |
| Metoprolol Tartrate | Metoprolol Tartrate | 317 | 104 |
| Tamsulosin Hcl | Tamsulosin Hcl | 293 | 97 |
| Valsartan | Valsartan | 290 | 104 |
| Simvastatin | Simvastatin | 284 | 92 |
| Hydrochlorothiazide | Hydrochlorothiazide | 281 | 101 |
| Trazodone Hcl | Trazodone Hcl | 272 | 96 |
| Duloxetine Hcl | Duloxetine Hcl | 247 | 78 |
| Eliquis | Apixaban | 245 | 67 |
| Clopidogrel | Clopidogrel Bisulfate | 241 | 74 |
| Furosemide | Furosemide | 221 | 84 |
| Pantoprazole Sodium | Pantoprazole Sodium | 220 | 70 |
| Sertraline Hcl | Sertraline Hcl | 207 | 79 |
| Potassium Chloride | Potassium Chloride | 206 | 68 |
| Pravastatin Sodium | Pravastatin Sodium | 203 | 68 |
| Montelukast Sodium | Montelukast Sodium | 197 | 66 |
| Allopurinol | Allopurinol | 187 | 66 |
| Lorazepam | Lorazepam | 186 | 55 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 174 | 63 |
| Prednisone | Prednisone | 173 | 138 |
| Alendronate Sodium | Alendronate Sodium | 163 | 60 |
| Fluticasone Propionate | Fluticasone Propionate | 163 | 58 |
| Carvedilol | Carvedilol | 162 | 61 |
| Clonazepam | Clonazepam | 160 | 36 |
| Famotidine | Famotidine | 138 | 49 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 135 | 29 |
| Xarelto | Rivaroxaban | 134 | 32 |
| Meloxicam | Meloxicam | 127 | 51 |
| Zolpidem Tartrate | Zolpidem Tartrate | 125 | 57 |
| Temazepam | Temazepam | 124 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 121 | 43 |
| Glimepiride | Glimepiride | 111 | 41 |
| Diazepam | Diazepam | 110 | 27 |
| Synthroid | Levothyroxine Sodium | 109 | 33 |
| Jardiance | Empagliflozin | 107 | 34 |
| Donepezil Hcl | Donepezil Hcl | 103 | 27 |
| Tizanidine Hcl | Tizanidine Hcl | 102 | 50 |
| Ezetimibe | Ezetimibe | 98 | 37 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 95 | 75 |
| Finasteride | Finasteride | 92 | 34 |
| Spironolactone | Spironolactone | 92 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 88 | 82 |
| Oxycodone Hcl | Oxycodone Hcl | 88 | 23 |
| Atenolol | Atenolol | 85 | 29 |
| Bupropion Xl | Bupropion Hcl | 84 | 29 |
| Metformin Hcl Er | Metformin Hcl | 83 | 28 |
| Warfarin Sodium | Warfarin Sodium | 79 | 26 |
| Chlorthalidone | Chlorthalidone | 75 | 26 |
| Pregabalin | Pregabalin | 75 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 73 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 71 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 71 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 70 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 69 | 21 |
| Ozempic | Semaglutide | 66 | 21 |
| Mirtazapine | Mirtazapine | 62 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 62 | 26 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 61 | 21 |
| Azelastine Hcl | Azelastine Hcl | 56 | 32 |
| Irbesartan | Irbesartan | 55 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 55 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 55 | 20 |
| Sildenafil Citrate | Sildenafil Citrate | 53 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 18 |
| Lovastatin | Lovastatin | 52 | 17 |
| Mounjaro | Tirzepatide | 52 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 48 | 17 |
| Celecoxib | Celecoxib | 47 | 16 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 47 | suppressed |
| Glipizide | Glipizide | 45 | 14 |
| Memantine Hcl | Memantine Hcl | 43 | 12 |
| Januvia | Sitagliptin Phosphate | 41 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Baclofen | Baclofen | 39 | 21 |
| Glipizide Er | Glipizide | 39 | 14 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 37 | suppressed |
| Azithromycin | Azithromycin | 37 | 37 |
| Enalapril Maleate | Enalapril Maleate | 37 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 22 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 36 | 15 |
| Farxiga | Dapagliflozin Propanediol | 35 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 35 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 35 | 15 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 34 | 34 |
| Diclofenac Sodium | Diclofenac Sodium | 34 | 14 |
| Digoxin | Digoxin | 34 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 29 |
| Valacyclovir | Valacyclovir Hcl | 34 | 14 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 32 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Bumetanide | Bumetanide | 31 | 16 |
| Methylprednisolone | Methylprednisolone | 31 | 31 |
| Testosterone Cypionate | Testosterone Cypionate | 31 | 12 |
| Droplet Pen Needle | Pen Needle, Diabetic | 30 | suppressed |
| Estradiol | Estradiol | 30 | 14 |
| Clonidine Hcl | Clonidine Hcl | 29 | 14 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 29 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 29 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 29 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 28 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 28 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Topiramate | Topiramate | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | 12 |
| Meclizine Hcl | Meclizine Hcl | 25 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Eszopiclone | Eszopiclone | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Tadalafil | Tadalafil | 22 | suppressed |
| Testosterone | Testosterone | 22 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Indapamide | Indapamide | 21 | suppressed |
| Nystatin | Nystatin | 21 | 12 |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | 17 |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 19 | suppressed |
| Metolazone | Metolazone | 19 | suppressed |
| Ranolazine Er | Ranolazine | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 19 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | 13 |
| Lactulose | Lactulose | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | 11 |
| Nitroglycerin | Nitroglycerin | 16 | 15 |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Eplerenone | Eplerenone | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Roflumilast | Roflumilast | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Enbrel | Etanercept | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Jantoven | Warfarin Sodium | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.80 · 1 records | GlaxoSmithKline, LLC. | AREXVY, SHINGRIX | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Arexvy play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error